Acute Pain Market Forecast Signals Accelerated Growth at a CAGR of 12% During the Forecast Period (2026-2036), Driven by Novel Non-Opioid Therapies and Expanding Treatment Options | DelveInsight
The acute pain market is witnessing steady growth, driven by the increasing adoption of multimodal pain management approaches, along with growing demand for non-opioid and long-acting analgesics. Additionally, the expected launch of emerging therapies such as Rizatriptan (RizaFilm)...
The acute pain market is witnessing steady growth, driven by the increasing adoption of multimodal pain management approaches, along with growing demand for non-opioid and long-acting analgesics. Additionally, the expected launch of emerging therapies such as Rizatriptan (RizaFilm)...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.